199 related articles for article (PubMed ID: 25990623)
1. Metastasis initiating cells in primary prostate cancer tissues from transurethral resection of the prostate (TURP) predicts castration-resistant progression and survival of prostate cancer patients.
Li Q; Li Q; Nuccio J; Liu C; Duan P; Wang R; Jones LW; Chung LW; Zhau HE
Prostate; 2015 Sep; 75(12):1312-21. PubMed ID: 25990623
[TBL] [Abstract][Full Text] [Related]
2. Multiplexed quantum dot labeling of activated c-Met signaling in castration-resistant human prostate cancer.
Hu P; Chu GC; Zhu G; Yang H; Luthringer D; Prins G; Habib F; Wang Y; Wang R; Chung LW; Zhau HE
PLoS One; 2011; 6(12):e28670. PubMed ID: 22205960
[TBL] [Abstract][Full Text] [Related]
3. Convergent RANK- and c-Met-mediated signaling components predict survival of patients with prostate cancer: an interracial comparative study.
Hu P; Chung LW; Berel D; Frierson HF; Yang H; Liu C; Wang R; Li Q; Rogatko A; Zhau HE
PLoS One; 2013; 8(9):e73081. PubMed ID: 24066029
[TBL] [Abstract][Full Text] [Related]
4. Plasma macrophage-stimulating protein and hepatocyte growth factor levels are associated with prostate cancer progression.
Sugie S; Mukai S; Yamasaki K; Kamibeppu T; Tsukino H; Kamoto T
Hum Cell; 2016 Jan; 29(1):22-9. PubMed ID: 26250899
[TBL] [Abstract][Full Text] [Related]
5. RANK- and c-Met-mediated signal network promotes prostate cancer metastatic colonization.
Chu GC; Zhau HE; Wang R; Rogatko A; Feng X; Zayzafoon M; Liu Y; Farach-Carson MC; You S; Kim J; Freeman MR; Chung LW
Endocr Relat Cancer; 2014 Apr; 21(2):311-26. PubMed ID: 24478054
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of putative cancer stem cell markers in the bone marrow of prostate cancer patients is associated with bone metastasis progression.
Ricci E; Mattei E; Dumontet C; Eaton CL; Hamdy F; van der Pluije G; Cecchini M; Thalmann G; Clezardin P; Colombel M
Prostate; 2013 Dec; 73(16):1738-46. PubMed ID: 24115186
[TBL] [Abstract][Full Text] [Related]
7. Prostate stem cell antigen mRNA expression in preoperatively negative biopsy specimens predicts subsequent cancer after transurethral resection of the prostate for benign prostatic hyperplasia.
Zhao Z; Liu J; Li S; Shen W
Prostate; 2009 Sep; 69(12):1292-302. PubMed ID: 19462463
[TBL] [Abstract][Full Text] [Related]
8. Tumor cytoreduction results in better response to androgen ablation--a preliminary report of palliative transurethral resection of the prostate in metastatic hormone sensitive prostate cancer.
Qin XJ; Ma CG; Ye DW; Yao XD; Zhang SL; Dai B; Zhang HL; Shen YJ; Zhu Y; Zhu YP; Shi GH; Xiao WJ; Lin GW; Swanson GP
Urol Oncol; 2012; 30(2):145-9. PubMed ID: 20451424
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of putative cancer stem cell markers in primary prostate cancer is associated with progression of bone metastases.
Colombel M; Eaton CL; Hamdy F; Ricci E; van der Pluijm G; Cecchini M; Mege-Lechevallier F; Clezardin P; Thalmann G
Prostate; 2012 May; 72(7):713-20. PubMed ID: 21882211
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor regulates myeloid cell leukemia-1 expression through neuropilin-1-dependent activation of c-MET signaling in human prostate cancer cells.
Zhang S; Zhau HE; Osunkoya AO; Iqbal S; Yang X; Fan S; Chen Z; Wang R; Marshall FF; Chung LW; Wu D
Mol Cancer; 2010 Jan; 9():9. PubMed ID: 20085644
[TBL] [Abstract][Full Text] [Related]
11. Prediction of survival benefit using an automated bone scan index in patients with castration-resistant prostate cancer.
Mitsui Y; Shiina H; Yamamoto Y; Haramoto M; Arichi N; Yasumoto H; Kitagaki H; Igawa M
BJU Int; 2012 Dec; 110(11 Pt B):E628-34. PubMed ID: 22788759
[TBL] [Abstract][Full Text] [Related]
12. Contemporary outcomes of palliative transurethral resection of the prostate in patients with locally advanced prostate cancer.
Pelletier J; Cyr SJ; Julien AS; Fradet Y; Lacombe L; Toren P
Urol Oncol; 2018 Aug; 36(8):363.e7-363.e11. PubMed ID: 29880461
[TBL] [Abstract][Full Text] [Related]
13. PSCA mRNA expression in preoperatively negative prostate biopsies predicts incidental prostate cancer in patients undergoing transurethral resection of the prostate for benign prostatic hyperplasia.
Zhao Z; Ma W; Zeng G; Qi D
J Surg Oncol; 2011 Nov; 104(6):672-8. PubMed ID: 21674503
[TBL] [Abstract][Full Text] [Related]
14. DU145 human prostate cancer cells express functional receptor activator of NFkappaB: new insights in the prostate cancer bone metastasis process.
Mori K; Le Goff B; Charrier C; Battaglia S; Heymann D; Rédini F
Bone; 2007 Apr; 40(4):981-90. PubMed ID: 17196895
[TBL] [Abstract][Full Text] [Related]
15. MET expression during prostate cancer progression.
Verhoef EI; Kolijn K; De Herdt MJ; van der Steen B; Hoogland AM; Sleddens HF; Looijenga LH; van Leenders GJ
Oncotarget; 2016 May; 7(21):31029-36. PubMed ID: 27105539
[TBL] [Abstract][Full Text] [Related]
16. Could the sextant prostate biopsy be replaced by transurethral resection?
Startsev VY; Pouline I; Gorelov S; Merkulova R
Arch Ital Urol Androl; 2005 Dec; 77(4):194-8. PubMed ID: 16444931
[TBL] [Abstract][Full Text] [Related]
17. Keratin 13 expression reprograms bone and brain metastases of human prostate cancer cells.
Li Q; Yin L; Jones LW; Chu GC; Wu JB; Huang JM; Li Q; You S; Kim J; Lu YT; Mrdenovic S; Wang R; Freeman MR; Garraway I; Lewis MS; Chung LW; Zhau HE
Oncotarget; 2016 Dec; 7(51):84645-84657. PubMed ID: 27835867
[TBL] [Abstract][Full Text] [Related]
18. Potential role of the OPG/RANK/RANKL axis in prostate cancer invasion and bone metastasis.
Li X; Liu Y; Wu B; Dong Z; Wang Y; Lu J; Shi P; Bai W; Wang Z
Oncol Rep; 2014 Dec; 32(6):2605-11. PubMed ID: 25333856
[TBL] [Abstract][Full Text] [Related]
19. Is computed tomography a necessary part of a metastatic evaluation for castration-resistant prostate cancer? Results from the Shared Equal Access Regional Cancer Hospital Database.
Hanyok BT; Howard LE; Amling CL; Aronson WJ; Cooperberg MR; Kane CJ; Terris MK; Posadas EM; Freedland SJ
Cancer; 2016 Jan; 122(2):222-9. PubMed ID: 26484853
[TBL] [Abstract][Full Text] [Related]
20. [Incidental carcinoma of the prostate: can we and should we recommend radical prostatectomy?].
Paul R; Knebel C; van Randenborgh H; Kübler H; Alschibaja M; Günther M; Hartung R
Urologe A; 2005 Sep; 44(9):1052, 1054-8. PubMed ID: 15965641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
